Search Results - "Andersson, B.S"

A Randomized Phase III Trial Of Busulfan + Melphalan (Bu-Mel) Vs Melphalan Alone For Multiple Myeloma: Longer PFS In The Bu-Mel Arm by Qazilbash, M.H, Bashir, Q, Thall, P, Kebriaei, P, Shah, N, Patel, K, Andersson, B.S, Nieto, Y, Valdez, B, Parmar, S, Delgado, R, Shah, J, Orlowski, R.Z, Champlin, R.E

Get full text

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma by Qazilbash, M.H, Chen, J, Valdez, B.C, Kawedia, J, Bashir, Q, Hosing, C.M, Kebriaei, P, Nieto, Y, Parmar, S, Shah, N, Shpall, E.J, Andersson, B.S, Champlin, R.E, Popat, U

Get full text

Epigenetic Changes Enhance the Cytotoxicity of Combined Nucleoside Analog-Dna Alkylating Agents in Lymphoma Cells by Valdez, B.C, Nieto, Y, Murray, D, Li, Y, Wang, G, Champlin, R.E, Andersson, B.S

Get full text

Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect? by Andersson, B S, Valdez, B C

Get full text

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation by Shannon, V R, Andersson, B S, Lei, X, Champlin, R E, Kontoyiannis, D P

“…Pulmonary infiltrates frequently complicate hematopoietic SCT (HSCT). The utility of fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) in the…”
Get full text

Thiotepa (Tt), Busulfan (Bu), and Clofarabine (Clo) as a Conditioning Therapy for Allogeneic Hematopoetic Stem Cell Transplant for Patients with High Risk Malignancies: Updated Response and Engraftment Data by Worth, L.L, Andersson, B.S, Kelly, S.S, Petropoulos, D, Lee, D.A, Kebriaei, P, Cooper, L.J.N, Champlin, R.E

Get full text

Purine Nucleoside Analogs Exert Synergistic Cytotoxicity With the DNA-Alkylating Agent Busulfan in Human Myeloid Leukemia by Wang, G, Valdez, B.C, Li, Y, Murray, D, Champlin, R.E, Andersson, B.S

Get full text

Synergistic Cytotoxicity of Busulfan and Nucleoside Analogs in Human Lymphoid Cell Lines by Valdez, B.C, Wang, G, Li, Y, Murray, D, Champlin, R.E, Andersson, B.S

Get full text

Synergistic Cytotoxicity Of Clofarabine, Fludarabine And Busulfan: Relevance To Myeloablative Therapy by Valdez, B.C, Li, Y, Murray, D, Champlin, R.E, Andersson, B.S

Get full text

Epigenetic Regulations Influence CML Cell Sensitivity to Busulfan: Relevance to Pretransplant Conditioning Therapy by Valdez, B.C, Li, Y, Murray, D, Champlin, R.E, Andersson, B.S

Get full text

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial by de Lima, M, McMannis, J, Gee, A, Komanduri, K, Couriel, D, Andersson, B S, Hosing, C, Khouri, I, Jones, R, Champlin, R, Karandish, S, Sadeghi, T, Peled, T, Grynspan, F, Daniely, Y, Nagler, A, Shpall, E J

“…The copper chelator tetraethylenepentamine (TEPA; StemEx) was shown to attenuate the differentiation of ex vivo cultured hematopoietic cells resulting in…”
Get full text

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients by Abudayyeh, A., Hamdi, A., Lin, H., Abdelrahim, M., Rondon, G., Andersson, B. S., Afrough, A., Martinez, C. S., Tarrand, J. J., Kontoyiannis, D. P., Marin, D., Gaber, A. O., Salahudeen, A., Oran, B., Chemaly, R. F., Olson, A., Jones, R., Popat, U., Champlin, R. E., Shpall, E. J., Winkelmayer, W. C., Rezvani, K.

“…Nephropathy due to BK virus (BKV) infection is an evolving challenge in patients undergoing hematopoietic stem cell transplantation (HSCT). We hypothesized…”
Get full text

Cidofovir Treatment Of BK-virus Related Hemorrhagic Cystitis Early After Allogeneic Stem Cell Transplantation (HSCT) For Malignant Diseases by Chu, D.T, Gulbis, A.M, Howell, J.E, de Lima, M, Matteo, P, Ciurea, S, Thall, P.F, Champlin, R.E, Andersson, B.S

Get full text

Clofarabine ± Fludarabine and IV Busulfan With Allogeneic Stem Cell Transplantation for Advanced Myeloid Leukemia (ML) and MDS by Andersson, B.S, Valdez, B.C, Thall, P.F, Wang, X, Worth, L.L, Popat, U, Alousi, A, Hosing, C, Jones, R.B, Shpall, E.J, de Lima, M, Champlin, R.E

Get full text

Early Mixed Chimerism Does Not Alter Long-Term Prognosis for Patients Receiving IV Busulfan-Fludarabine (Iv Bu-Flu) With Allogeneic Stem Cell Transplantation for AML/MDS by Tang, X, de Lima, M, Wei, W, Chiattone, A, Thall, P.F, Medeiros, L.J, Rondon, G, Shpall, E.J, Jones, R.B, Nieto, Y, Alousi, A, Champlin, R.E, Andersson, B.S

Get full text

Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers by Tsimberidou, A.-M., Ma, H., Stewart, C., Schoor, O., Maurer, D., Mendrzyk, R., Satelli, A., Fritsche, J., Stephens, G., Mohamed, A., Hwu, P., Yee, C., Reinhardt, C., Weinschenk, T., Gharpure, K., Stungis, A., Vining, D.J., Singh, H., Walter, S., Andersson, B.S.

Get full text

Safety Of T-Cell Replete Haploidentical Stem Cell Transplantation Using Fludarabine, Melpahalan And Thiotepa Conditioning And High-Dose Post-Transplant Cyclophosphamide by Ciurea, S.O, de Lima, M, Kebriaei, P, Rondon, G, Saliba, R, McMannis, J, Andersson, B.S, Khouri, I.F, Giralt, S, Champlin, R.E

Get full text

Faster Lymphocyte Recovery After Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts For Decreased Non-Relapse Mortality (NRM) In Adults With Acute Lymphoblastic Leukemia (ALL) by Yuen, C.H, Saliba, R.M, Andersson, B.S, Shpall, E, Popat, U.R, Qazilbash, M.H, Hosing, C, de Lima, M.J, Giralt, S.A, Champlin, R.E, Kebriaei, P

Get full text

Thiotepa (TT), Busulfan (Bu), And Clofarabine (Clo) As A Conditioning Therapy For Allogeneic Hematopoetic Stem Cell Transplant For Patients With High Risk Malignancies: Early Response And Engraftment Data by Worth, L.L, Andersson, B.S, Kazerooni, R, Petropoulos, D, Kelly, S.S, Lee, D.A, Du, M, Madden, T.L, deLima, M.J, Champlin, R.E, Cooper, L.J.N

Get full text

Clofarabine ± Fludarabine With IV Busulfan And Allogeneic Stem Cell Transplantation For Relapsed, Refractory Myeloid Leukemia (ML) And MDS by Andersson, B.S, de Lima, M, Valdez, B.C, Thall, P.F, Worth, L.L, Popat, U, Jones, R.B, Shpall, E.J, Madden, T, McAdams, P.L, Alousi, A.M, Rondon, G, Kebriaei, P, Champlin, R.E

Get full text